CBD Drug Interactions: CYP3A4, Blood Thinners, SSRIs, and the Grapefruit Rule
CBD shares liver enzymes with a long list of prescriptions. This is the practical interaction list — warfarin, clobazam, some statins, and more.
Most CBD drug interactions explainers stop at “ask your doctor.” That sentence is true and useless. Cannabidiol inhibits CYP3A4, CYP2C19, CYP2C9, CYP2D6, CYP2C8, and some UGTs in vitro. In people, the interaction that is documented hardest is clobazam: N-desmethylclobazam, the active metabolite, goes up. The consumer shorthand is the grapefruit rule. If a leaflet says avoid grapefruit, treat hemp CBD as a pharmacist question, not a wellness add-on.
The FDA’s consumer update on cannabis and cannabis-derived products is the right external bookmark, because it frames CBD as a pharmacologically active oil, not a vitamin: What you need to know about products containing cannabis or cannabis-derived compounds (FDA). The best-documented interaction sheet in medicine is still the Epidiolex (prescription cannabidiol) label. OTC hemp is not Epidiolex, but the enzymes do not care about your branding.
High-alert pairings include warfarin and other anticoagulants (including DOACs, with less CBD-specific data and more caution), clobazam, valproate, some SSRIs, some calcium channel blockers, tacrolimus, and certain statins. Never stop a prescription to “make room” for CBD. Side effects people notice first — sleepiness, diarrhea, elevated liver enzymes — live on CBD side effects. The liver-lab story is its own page: is CBD bad for your liver.
The grapefruit rule, without the cartoon
Grapefruit juice inhibits intestinal CYP3A4. More of some pills reach blood. CBD is a broader enzyme pest than a glass of juice, and it is taken daily by people who think of it as tea. The rule is a filter, not a complete list. Some grapefruit-sensitive drugs will matter. Some CBD interactions (clobazam via CYP2C19, warfarin via CYP2C9) are not the poster grapefruit story and still matter.
| Enzyme / pathway | What CBD can do | Example drugs people actually take | Practical move |
|---|---|---|---|
| CYP3A4 | Inhibition in vitro; can raise levels of sensitive substrates | Some statins (simvastatin, lovastatin; atorvastatin in part), some calcium channel blockers, some benzodiazepines, some immunosuppressants | If the label mentions grapefruit or CYP3A4, pharmacist first. Do not add CBD the same week you change the statin dose. |
| CYP2C19 | Inhibition; clinically important with clobazam | Clobazam (N-desmethylclobazam rises); some SSRIs and other 2C19 substrates | Seizure medicines are not a DIY stack. Epidiolex clinics already monitor this. |
| CYP2C9 | Inhibition in vitro; INR risk is the fear with warfarin | Warfarin; other 2C9 substrates | If you are anticoagulated, CBD is a prescriber-and-INR conversation, not a gummy. |
| CYP2D6, CYP2C8 | Inhibition in vitro | Various antidepressants, some beta blockers, some antidiabetics — list is long and drug-specific | Bring the full med list. “I’m on a depression pill” is not enough. |
| UGTs | Inhibition in vitro | Some drugs cleared by glucuronidation | Specialist drugs (including some anticonvulsants) need the label, not a blog. |
| Additive sedation / GI / liver | Not always a CYP math problem | Alcohol, other sedatives, valproate (hepatic), high-dose acetaminophen load | Two sleepy drugs still make a sleepy person. Liver stacking is a separate risk. |
This table is a map of where to worry, not a license to keep or dump a medicine. OTC ibuprofen is a different, narrower question — gut and kidney more than a famous CYP clash at typical doses — covered in can you take CBD with ibuprofen. Do not generalize that page to warfarin.
High-alert list in plain English
Clobazam. This is the interaction with receipts. CBD inhibits CYP2C19; N-desmethylclobazam rises, sometimes several-fold in Epidiolex data. Sleepiness and the need to adjust clobazam are why neurology clinics that use prescription CBD already watch it. An Amazon tincture on top of clobazam is the same enzymes without the clinic.
Valproate. The worry is liver injury, not a clever CYP trick. Epidiolex labeling already flags hepatocellular injury, worse with valproate. If you or a child is on valproate, OTC hemp is not a casual sleep aid.
Warfarin and other anticoagulants. CYP2C9 inhibition can raise warfarin effect. Case reports exist of INR climbing after CBD. DOACs (apixaban, rivaroxaban, and others) have their own CYP3A4/P-gp stories; dedicated CBD+DOAC trials are not a thick file. Bleeding risk is not the place to be an early adopter. If you take a blood thinner, you need a prescriber, not a dose-titration blog.
Tacrolimus and other narrow-therapeutic-index immunosuppressants. Levels matter to the decimal. CBD has raised tacrolimus concentrations in published cases. Transplant medicines are not “ask the budtender.”
Some SSRIs and other psychiatric meds. Several are CYP2C19 or CYP2D6 substrates. The clinical picture may be more sedation, more GI, or a level change you will not feel until it is a problem. SSRIs are not forbidden by a cartoon. They are a pharmacist review. Do not stop an SSRI because a forum said hemp replaces it.
Some calcium channel blockers and some statins. CYP3A4 substrates with grapefruit warnings are the obvious screen. Muscle pain, dizziness, or a sudden change after adding CBD is a call, not a “push through.”
Epidiolex itself. If the prescription is already cannabidiol, adding a store tincture is stacking the same molecule without the titration schedule. Do not double CBD off-label because the gummy was on sale.
How to have the five-minute pharmacist conversation
Pharmacists cannot review a product you describe as “the hemp from the gas station.” They need names and milligrams. Ranking pages tell you to “disclose CBD.” This is the actual script.
- Print or screenshot the supplement facts and the COA lot. Isolate vs full-spectrum vs a delta-8 blend is not a detail. A blend is a different drug interaction problem.
- List every prescription, OTC, and vitamin, including grapefruit-sensitive ones you already ignore. Include clobazam, valproate, warfarin/DOACs, SSRIs, calcium channel blockers, tacrolimus, statins, and seizure meds by name.
- Say the milligrams of CBD per day you plan to take, not “a dropper.” Epidiolex interactions were mapped at drug doses; risk is not linear down to 5 mg, but it is also not zero at consumer doses for narrow-index drugs.
- Ask which of your drugs is a CYP3A4, 2C19, or 2C9 substrate with a narrow window. Ask what monitoring already exists (INR, LFTs, drug levels).
- If they say no, that is an answer. If they say “probably fine at 20 mg, not at 300,” that is also an answer. Write it down.
- Never stop the prescription on a Friday to start oil on Saturday. If something needs to change, the prescriber changes it.
- Re-ask when a dose changes, when a new antibiotic or antifungal appears (those are famous CYP inhibitors too), or when you jump from 25 mg to 150 mg because “it stopped working.”
- If you feel new bruising, unusual sleepiness, vomiting, yellow skin, dark urine, or a seizure-pattern change, that is urgent care, not a Reddit titration.
Topical CBD on intact skin is a smaller systemic load than an oil you swallow. It is not a free pass if you slather a high-milligram product over a large area of broken skin. Inhaled hemp is a fast spike. Neither format erases CYP inhibition; they change how much and how fast.
What is not an interaction, and what people still get wrong
Caffeine is not a classic CBD contraindication. People still stack coffee and oil; that is a timing and stomach issue more than a warfarin-level problem. Alcohol plus CBD is sedation and judgment, and alcohol plus CBD plus acetaminophen is a liver-load pile. Those are stacking harms, not always a named CYP pair.
“Natural” is not a clearance. St. John’s wort induces CYP3A4 and can shove levels the other way. Grapefruit, goldenseal, and CBD in the same cabinet is a hobbyist experiment. Pick fewer variables.
Pets on phenobarbital or other anticonvulsants need a veterinarian, not a fraction of your tincture. This page is human drug interaction. Veterinary CYP math is not a kitchen-scale problem.
Pregnancy, nursing, and chemotherapy protocols are automatic specialist conversations. Do not add CBD because nausea or sleep is bad. The oncology team already has antiemetics with known interaction files.
FAQ
What is the grapefruit rule for CBD?
If a drug label warns against grapefruit, CBD may affect the same CYP3A4 pathway and should be cleared by a pharmacist. It is a shorthand, not a complete list. Clobazam and warfarin sit on other enzymes and still matter.
Which medicines are high-alert with CBD?
Clobazam, valproate, warfarin and other anticoagulants, tacrolimus, some SSRIs, some calcium channel blockers, and certain statins. The Epidiolex label is the best-documented interaction sheet. Your list may be longer. Bring it.
Can I stop my prescription if I start CBD?
No. Never stop a prescription to make room for CBD. If a combination is a bad idea, the prescriber decides what changes. Stopping clobazam, warfarin, or an SSRI on your own is the danger, not the blog post.
Are small gummy doses safe with everything?
No blanket yes. Risk scales with milligrams, with how sensitive the other drug is, and with liver health. A 10 mg isolate is not Epidiolex, and it is not automatically harmless next to tacrolimus. Ask with numbers.
Disclaimer: This article is for education only. It is not medical advice, not a complete interaction checker, and not a reason to start or stop any medicine. CBD products are not FDA-approved to diagnose, treat, cure, or prevent any disease, except the prescription medicine Epidiolex for certain seizures. Talk to a clinician or pharmacist who can see your full medication list before using hemp CBD.
Related CBD guides
Can You Overdose on CBD? Lethal Dose vs What Actually Goes Wrong
You are unlikely to die from too much CBD. You can still wreck a day with diarrhea, fog, and — at higher daily milligrams — liver enzyme changes.